Description
A prodrug form of 5-ASA; cleaved by bacterial azoreductases in the intestinal lumen to release 5-ASA; decreases IL-2 levels and increases IL-6 levels in the serum and colonic mucosa membrane, as well as decreases micro- and macroscopic colonic damage, in a rat model of DNCB-induced colitis at 600 mg/kg per day
Formal name: 5-[(1E)-2-[4-[[(2-carboxyethyl)amino]carbonyl]phenyl]diazenyl]-2-hydroxy-benzoic acid
Synonyms:
Molecular weight: 357.3
CAS: 80573-04-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Immunology & Inflammation|Gastric Disease|Ulcerative Colitis